Why a URI study is examining the link between ADHD and alcohol use disorder
Q. What do we know about the link between ADHD and alcohol use disorder right now?
Advertisement
Stamates:
That 18 to 25
[year old]
period when people are transitioning to young adulthood ... there hasn't been as much research focused to that age range. And so what we do know is that the folks who continue to have symptoms related to ADHD into adulthood, they're at higher risk for developing a substance use disorder. If they do receive treatment, they usually have poor treatment outcomes, so they're more likely to relapse. If they have to go to an inpatient facility, they have a longer stay at that facility, and so it just increases the risk of having more symptoms related to substance use disorders and less … improved treatment outcomes.
Get Rhode Island News Alerts
Sign up to get breaking news and interesting stories from Rhode Island in your inbox each weekday.
Enter Email
Sign Up
"What we are examining is their executive functioning skills … and how that relates to the development of alcohol use disorder symptoms," URI psychology professor Amy Stamates said.
University of Rhode Island
What will your research explore?
We just wrapped up year three. What we are looking at is among college students who have ADHD, we're comparing them to college students who do not have ADHD. What we are examining is their executive functioning skills … and how that relates to the development of alcohol use disorder symptoms. So there are certain symptoms that we might look for, things like craving, and then are they experiencing any problems related to their drinking? And so we're looking at that over [a] one-year period through some different technological advances that we have in research.
Advertisement
With executive functioning, it's a really complicated thing to study. Executive functioning skills are really important, cognitive skills that we need for daily functioning. So we use these every day to solve problems and make decisions. We're processing information, we're learning how to control our behavior, and obviously folks with ADHD might have issues with some of these skills, but that doesn't look the same for everybody with ADHD. And so what we're looking at is what specific types of executive functioning are important for the young adults with ADHD, and how do these relate to their substance use problems.
This study is supported by a grant from the National Institutes of Health. With all the federal cutbacks to research funding
, are you concerned about whether
that will impact your work
?
I think everyone's concerned about how this will impact their research. I think that for this particular focus, substance use problems, they're not going away. I think that NIH will continue to fund this type of work, but we don't really know what the budgets are going to look like long term.
You're also the director of URI's Health and Alcohol-Related Problems Lab. Can you tell me a little bit about what the lab does?
Advertisement
We're really interested in different approaches to studying substance use problems, and so in my lab ... we actually give participants alcohol in the lab to see how they respond to it. And so what we're looking at is if I give you alcohol in the lab, how does that impact your decision-making in the lab, how does that impact your motivation to drink more alcohol? We look at that behaviorally in the lab.
The other thing that we do in my work is a data collection method called ecological momentary assessment. And this type of method has become critical to looking at substance use behavior, because participants download an app on their phone and then we just send them surveys throughout the day to ask them, where are you? Who are you with? Did you use substances? We ask things about like, if you're at a party did you drive? Do you have a designated driver? And then the next morning, we might ask things about, you know, do you have a hangover? Did you black out last night? So we're getting more detailed information about what actually is going on, versus when they come in the lab.
What about our relationship with alcohol concerns you most? And are there glimmers of hope in improving our relationship?
Researchers don't do a good job at talking about the risk associated with alcohol, and a lot of people don't know that alcohol use is a carcinogen. It increases the risk of cancer, other health issues and different types of chronic disease, and I think a lot of that isn't common knowledge among folks.
Advertisement
The other part that's hopeful is …. younger adolescents and younger adults right now are engaging in less alcohol use than traditionally. Part of that could be because there's other things going on — they're not going out, they're isolating in their house, or they're not actually going to parties and things like that, but we're generally seeing a downward trend. So I think that's hopeful.
This interview has been edited for length and clarity.
The Boston Globe's weekly Ocean State Innovators column features a Q&A with Rhode Island innovators who are starting new businesses and nonprofits, conducting groundbreaking research, and reshaping the state's economy. Send tips and suggestions to reporter Alexa Gagosz at
.
Christopher Gavin can be reached at
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time Business News
13 hours ago
- Time Business News
Parents' Experiences: Strattera vs Adderall for Young Kids
When a child is diagnosed with ADHD, parents often face the difficult decision of choosing the most suitable treatment. Two of the most commonly prescribed medications are Strattera vs adderall. While both aim to help manage ADHD symptoms, they differ significantly in how they work and affect children. Understanding how other parents perceive these medications can provide valuable insight for those navigating this challenging decision. When it comes to treating anxiety and depression, finding the right medication can be a complex decision. Two commonly prescribed SSRIs are Lexapro vs zoloft, each with unique effects on mood and potential side effects. While both medications work by increasing serotonin levels in the brain, they may differ in how quickly they act or how well they're tolerated by different individuals. Factors like your medical history, other medications, and potential side effects should be considered. Consulting with a healthcare provider is essential to determine which option aligns best with your personal needs and treatment goals. Strattera is a non-stimulant medication that works by increasing levels of norepinephrine in the brain. Unlike Adderall, which is a stimulant, Strattera does not have immediate effects and may take several weeks to show benefits. Adderall, on the other hand, is a fast-acting stimulant that affects dopamine and norepinephrine levels, leading to a quicker response in terms of symptom management. These fundamental differences lead to varying experiences among parents and children. Many parents approach ADHD medications with caution, especially when the child is young. One common concern is the fear of personality changes or emotional blunting. Parents who chose Strattera often mention that they preferred starting with a non-stimulant to avoid the potential for stimulant-related side effects, such as sleep disturbances or appetite suppression. Others opted for Adderall because of the immediate need for symptom control, especially if behavioral issues were affecting school performance. Parents who have used Strattera for their children often describe the experience as a slow but steady journey. It typically takes several weeks to notice any improvement, which can test a parent's patience. However, many appreciate the subtle nature of the changes. One mother of a seven-year-old mentioned that her son became 'more thoughtful and less reactive' over time, without feeling sedated or overly quiet. Another parent shared that Strattera helped improve her daughter's emotional regulation and focus in school, with fewer emotional outbursts at home. However, the slower onset of action also proved frustrating for some. A few parents noted that their children did not respond to Strattera even after the full trial period, and they had to eventually switch to a stimulant. Side effects such as stomachaches, mood swings, or fatigue were also reported by some families, although they often resolved after dosage adjustments. Parents who opted for Adderall often report quicker results, sometimes within the first day or week of treatment. Many noted dramatic improvements in attention span, classroom behavior, and overall school performance. A father of a six-year-old shared that his son 'could finally sit through a lesson and follow instructions,' something that seemed impossible before starting Adderall. Others echoed this sentiment, saying their child was more engaged and less impulsive, both in school and at home. Despite its effectiveness, Adderall's side effects were a significant concern for many parents. Common issues included appetite suppression, difficulty sleeping, and increased irritability, particularly when the medication wore off in the evening. Some children experienced emotional crashes or became overly focused, leading to rigidity in thinking or behavior. One parent described how her daughter became 'laser-focused but anxious,' prompting a reevaluation of the dosage and timing. Many parents emphasized that medication, whether Strattera or Adderall, was just one part of a broader ADHD management plan. Behavioral therapy, consistent routines, diet changes, and strong communication with teachers were often mentioned as essential components. Parents appreciated doctors who took a holistic approach and encouraged regular check-ins to monitor the child's progress and adjust treatment accordingly. Some parents also found success in switching between medications or combining low doses of both under medical supervision. For example, a mother described starting her son on Strattera and later adding a small dose of Adderall to target specific school hours, which helped reduce side effects while maintaining effectiveness. Navigating ADHD treatment is not just a medical decision—it's an emotional journey. Parents often expressed feelings of guilt, worry, and self-doubt, especially during the early stages of treatment. Seeing improvements in their child's ability to function and succeed brought relief and even joy. At the same time, dealing with side effects or trial-and-error periods was emotionally draining. Several parents mentioned the importance of parent support groups, either in person or online, where they could share experiences and receive guidance. Children, too, were affected emotionally by their treatment experience. Some became more confident as they gained control over their behavior and received positive feedback from teachers. Others struggled with the stigma of taking medication or experienced self-esteem issues related to side effects. Open conversations, reassurance, and involving the child in age-appropriate decisions helped many families navigate these challenges. Every child with ADHD is unique, and so are their responses to medications like Strattera and Adderall. The experiences of parents reveal that while some children thrive on one medication, others may struggle. The key is working closely with healthcare providers, being patient during the trial period, and focusing on the child's overall well-being rather than just symptom control. Whether choosing Strattera for its gradual, non-stimulant benefits or Adderall for its quick symptom relief, parents play a crucial role in advocating for their child's needs and ensuring a balanced, personalized treatment approach. Their voices remind us that the journey may be complex, but with support and persistence, improvement is possible. TIME BUSINESS NEWS
Boston Globe
20 hours ago
- Boston Globe
Members of Paris youth choir ‘are OK' after experiencing seizure-like symptoms during performance at Cambridge church
All of the children 'are OK,' Patrick Moran, head of school at the 'As the news coverage of the concert last night grows, we have a happy update to share with you. As the fire chief expected, all of the singers from last evening's concert are OK,' Moran said in the message, which the Roman Catholic Archdiocese of Boston provided to the Globe. 'They were all discharged from the hospital in good condition late last night. The choir will provide us with a statement as soon as they are able.' Advertisement During the 6 p.m. performance, eight children reported feeling sickened by a smell, having trouble breathing, and experiencing 'seizure-like symptoms,' fire officials said in a statement. Fire crews went to the church around 7:30 p.m. The ill children were evaluated, treated on scene, and taken to local medical facilities, officials said. A firefighter carried to a child to an ambulance Tuesday night. Cambridge Fire Department/Facebook Approximately 70 other people in attendance were not affected, fire officials said. Advertisement The church was evacuated as a precaution, Cambridge's fire chief, Thomas Cahill, said Wednesday. After members of a French youth choir at St. Paul's church were hospitalized last night by an unidentified illness before a performance, the area was quiet in the morning in Harvard Square on July 23, 2025. Lane Turner/Globe Staff Cahill said a 911 caller reported a child was experiencing 'seizure-like symptoms.' When emergency responders reached the church, they found seven other children 'complaining of similar symptoms, though not witnessed by our EMS crews on scene,' Cahill said. Cahill confirmed that all eight children had been released from the hospital. Cahill said the building was ventilated and the hazmat team used metering equipment to determine the hazardous odor was no longer present. The choir originally planned to have a concert in Philadelphia on July 18 'but had a Covid breakout several days before and needed to cancel,' according to Amanda Schkeeper, director of advancement for the Philadelphia Boys and Girls Choirs. Another concert scheduled for July 19 at the First Presbyterian Church of Moorestown, N.J., was also canceled due to COVID, the church wrote on Facebook. Emily Sweeney can be reached at
Associated Press
a day ago
- Associated Press
Bonding Health Introduces Emotional Regulation Score™ – The First Clinical-Grade Tool to Help ADHD Adults and Parents Measure and Build Emotional Mastery
New York, NY - July 22, 2025 - Bonding Health, a innovative digital health company serving individuals and families impacted by ADHD, today announced the launch of its Emotional Regulation Score™, a new clinically validated feature that allows users to measure, develop, and track their ability to regulate their emotions. The new feature will launch on Friday, July 25, as part of Version 4 of the Bonding Health app, on iOS and Android. The Emotional Regulation Score™ (ERS), was developed using the Emotion Regulation Questionnaire (ERQ) which is a well-accepted gold standard in psychological science developed by Gross & John (2003). The ERS brings decades of research into an actionable, mobile-first app experience created exclusively for ADHD brains. 'Emotional regulation has generally been treated as an abstract skill,' said Pen King Jr., CEO of Bonding Health. 'Now with the Emotional Regulation Score™ we are changing the game. For the first time ever, ADHD adults and parents have a way to measure this critically important ability, develop the skill through structured supports, and follow their progress over time, as we do with trackers for physical health.' Addressing a Critical Need in ADHD Support Emotional regulation is one of the most substantial predictors of long-term well-being (just the mind, but the body and relationships). It has ramifications for mental clarity, physical wellness and the quality of relationships both personally and professionally. In order to make improvements in emotional regulation, it is essential to measure it, however there are few specific individuals are able to measure emotional regulation (specifically individuals with ADHD), and furthermore few practices to develop it. Bonding Health's Emotional Regulation Score™ provides a simple, data-driven mechanism to build self-awareness and emotional resilience. Key Features of the Emotional Regulation Score™ Expanding Support Through PKJ Coaching Bonding Health has teamed up with PKJ Coaching, a recognized leader in coaching programs focused on ADHD, to enhance user support. This partnership allows all users to not only learn from their Emotional Regulation Score™ but also receive personalized strategies and accountability to practice these skills in everyday life. Availability The Emotional Regulation Score™ will launch on Friday, July 25, 2025, with Version 4 of the Bonding Health app, available for both iOS and Android. Download now to be first in line: About Bonding Health Bonding Health is a digital health company that supports individuals and families affected by ADHD to achieve a higher degree of emotional balance and resilience. Importantly, Bonding Health offers clinician-designed tools, daily habit trackers, and collective resources such as PKJ Coaching that continue to provide evidence-based resources that allow individuals to thrive rather than focus on medication. Media Contact: Pen King Jr. CEO, Bonding Health [email protected] Media Contact Company Name: Bonding Health Contact Person: Pen King Jr. Email: Send Email State: New York Country: United States Website: Source: AIO Newswire
